Faculty
Eve T. Rodler, MD
Assistant Professor
Department of Medicine
Division of Oncology
Mailing Address
Seattle Cancer Care Alliance
825 Eastlake Ave E, G3-630
Seattle, WA 98109-1023
Admin Contact
Yaddi Ty
206.288.7518
yty@seattlecca.org
Fax: 206.288.6618
Specialty / Expertise
Sarcoma and Breast Cancer
Research Interests
Clinical Trials for Sarcoma and Breast Cancer
Current Research Projects
Anthropomorphized Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastic Soft- Tissue or Bone Sarcoma.
ET743-SAR-3002-A Multicenter, Open-Label Single-Arm Study of YONDELIS® (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment.
P04720-A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy.
A Phase II Multicenter, Parallel Group, Randomized Study Of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin In Subjects With Unresectable Or Metastatic Soft tissue Sarcoma.
A Ramdomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Seclective Src Kinase Inhibitor, In Patients with Recurrent Osterosarcom Localized to the Lung.
Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumors.
Pending-Phase I Study of ABT-888 in Combination with Cisplatin and Vinorelbine for Patients with Advanced Triple Negative Breast Cancer and/or BRCA-Mutation Associated Breast Cancer
Training
Dr. Rodler received her BA from Stanford University and her MA from Yale University. She completed her Post-baccalaureate pre-medical program from Columbia University and received her MD from George Washington University, School of Medicine. Her Internal Medicine Residency was completed at Harbor-UCLA Medical Center and her Hematology/Oncology Fellowship was completed at the University of California at Davis.
Selected Publications
Rodler E, Korde L, Gralow J. Current Treatment Options in Triple Negative Breast Cancer. Breast Disease. In press.
Pollack SM, Loggers ET, Rodler ET, Yee C, Jones RL. Immune Based Therapies for Sarcoma. Sarcoma 2011;2011:7 pgs.
Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C. Blastic Mantle Cell Lymphoma Developing Concurrently in a Patient with Chronic Myelogenous Leukemia and a Review of the Literature. American Journal of Hematology 2004;75:231-238.
Rodler E, Wun T. Surgical Issues Affecting Patients with Hematologic Malignancies. In: Lubin ME, Walker HK, Smith RB, Dobson TF, Spell N, (eds). Medical Management of the Surgical Patient, 4th edition, Cambridge Press, 2006.
Rodler E, Wun T. Surgical Issues Affecting Patients with Hematologic Malignancies. In: Lubin ME, Walker HK, Smith RB, Dobson TF, Spell N, (eds). Medical Management of the Surgical Patient, 4th edition, Cambridge Press, 2006.
Last updated: May 2010